v3.25.1
Balance Sheet Components - Schedule of Other Accrued Liabilities (Details) - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]    
Accrued contract manufacturing expenses $ 1,294 $ 1,071
Accrued clinical and research expenses 326 611
Accrued professional services $ 4,291 $ 8,682
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total other accrued liabilities Total other accrued liabilities
Current portion of lease liabilities $ 1,280 $ 1,572
Royalty obligation payable 3,336 2,951
Current portion of deferred royalty obligations 6,860 6,438
Accrued license fees and royalties 1,483 1,727
Other [1] 11,794 6,947
Total other accrued liabilities $ 30,664 $ 29,999
[1] Amount as of March 31, 2025 and December 31, 2024 includes $8.6 million and $5.3 million advance payments received from our partner for inventory supply as discussed in Note 4, “License and Collaboration Arrangements”.